HAP Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

HAP Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,600	Closed	-$2K	–	3037
2021 Q3	$2K	Buy	+10,600	New	+$124K	﹤0.01%	2350
2021 Q1	–	Sell	-28,200	Closed	-$73K	–	2756
2020 Q4	$73K	Buy	+28,200	New	+$407K	﹤0.01%	1282

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

HAP Trading's TRIL Position: Q4 2021 in Review

HAP Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 72,458 shares — an estimated $1.27M sold.

HAP Trading first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $1.27M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

HAP Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 72,458 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.27M.
HAP Trading first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
HAP Trading's Trillium Therapeutics Inc. position peaked at $1.27M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.